This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Top Research Reports for McDonald's, CVS Health & Celgene
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including McDonald's (MCD), CVS Health (CVS) and Celgene (CELG).
Agilent (A) Surpasses Earnings and Revenue Estimates in Q1
by Zacks Equity Research
Agilent (A) reports strong fiscal first-quarter results on broad-based growth in all its product lines.
Agilent Technologies (A) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Agilent (A) delivered earnings and revenue surprises of 4.11% and 1.02%, respectively, for the quarter ended January 2019. Do the numbers hold clues to what lies ahead for the stock?
Wal-Mart, CVS, Agilent, Hewlett-Packard and Kraft-Heinz are part of Zacks Earnings Preview
by Zacks Equity Research
Wal-Mart, CVS, Agilent, Hewlett-Packard and Kraft-Heinz are part of Zacks Earnings Preview
Will New Technologies Benefit Agilent (A) in Q1 Earnings?
by Zacks Equity Research
Agilent's (A) leadership position and strength in revenue segments are likely to aid fiscal first-quarter 2019 results.
3 Things to Know About Q4 Earnings Season
by Sheraz Mian
We continue to see the picture that emerged from the Q4 earnings season as not great, but it is not bad either.
Agilent Technologies (A) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Agilent (A) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Agilent (A) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Agilent (A) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
TE Connectivity (TEL) Q1 Earnings: What's in the Cards?
by Zacks Equity Research
TE Connectivity's (TEL) fiscal first-quarter 2019 results are expected to benefit from robust solutions portfolio and normalizing seasonal trend in the end-markets.
What's in the Offing for Waters Corp (WAT) in Q4 Earnings?
by Zacks Equity Research
Waters' (WAT) strong segmental and end-market performance is likely to drive fourth-quarter 2018 results.
Will Agilent (A) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Agilent (A) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Agilent (A) to Expand Cell Analysis Offerings in Ireland
by Zacks Equity Research
Agilent (A) is set to expand the Cork facility in Ireland in a bid to expand its capabilities in the cell analysis space.
Agilent Technologies (A) in Focus: Stock Moves 7.8% Higher
by Zacks Equity Research
Agilent Technologies (A) shares rose almost 8% in the last trading session, amid huge volumes.
Agilent (A) Surpasses Earnings and Revenue Estimates in Q4
by Zacks Equity Research
Agilent (A) reports strong fiscal fourth-quarter results on broad-based growth in all its product lines.
Agilent Technologies (A) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Agilent (A) delivered earnings and revenue surprises of 10.96% and 3.05%, respectively, for the quarter ended October 2018. Do the numbers hold clues to what lies ahead for the stock?
Agilent (A) Hikes Quarterly Dividend, Rewards Shareholders
by Zacks Equity Research
Agilent (A) hikes dividend to 16.4 cents per share in a bid to reward its shareholders.
Will New Technologies Benefit Agilent (A) in Q4 Earnings?
by Zacks Equity Research
Agilent's (A) leadership position and strength in revenue segments are likely to aid fiscal fourth-quarter 2018 results.
Agilent Technologies (A) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Agilent (A) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can Automotive Strength & Acquisitions Aid AVX Q2 Earnings?
by Zacks Equity Research
AVX's fiscal second-quarter results are likely to benefit from acquisitions and strength in the automotive market. However, weakness in the smartphone market might impact its results.
Agilent Technologies Enters Oversold Territory
by Zacks Equity Research
Agilent Technologies has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
TER vs. A: Which Stock Is the Better Value Option?
by Zacks Equity Research
TER vs. A: Which Stock Is the Better Value Option?
Agilent Technologies (A): Moving Average Crossover Alert
by Zacks Equity Research
Agilent Technologies, Inc. (A) is looking like an interesting pick from a technical perspective
Agilent Eyes Cell Analysis Portfolio Expansion, To Buy ACEA
by Zacks Equity Research
Agilent (A) agrees to acquire ACEA Biosciences (ACEA) for $250 million, in a bid to expand its share in the cell analysis market.
TER vs. A: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
TER vs. A: Which Stock Is the Better Value Option?
Electronics Testing Equipment Outlook: Solid Demand Ahead
by Zacks Equity Research
Electronics - Testing Equipment industry has growth potential, thanks to increasing proliferation of electronic devices in every major sector.